Dearborn Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $943K | Sell |
|
|||||
|
2025
Q1 | $996K | Buy |
|
|||||
|
2024
Q4 | $956K | Sell |
|
|||||
|
2024
Q3 | $1.17M | Buy |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q1 | $907K | Buy |
|
|||||
|
2023
Q4 | $795K | Sell |
|
|||||
|
2023
Q3 | $1.02M | Sell |
|
|||||
|
2023
Q2 | $1.24M | Buy |
|
|||||
|
2023
Q1 | $1.38M | Sell |
|
|||||
|
2022
Q4 | $1.77M | Sell |
|
|||||
|
2022
Q3 | $1.55M | Sell |
|
|||||
|
2022
Q2 | $1.94M | Buy |
|
|||||
|
2022
Q1 | $1.91M | Buy |
|
|||||
|
2021
Q4 | $2.02M | Sell |
|
|||||
|
2021
Q3 | $1.55M | Buy |
|
|||||
|
2021
Q2 | $1.29M | Sell |
|
|||||
|
2021
Q1 | $1.2M | Sell |
|
|||||
|
2020
Q4 | $1.23M | Sell |
|
|||||
|
2020
Q3 | $1.26M | Sell |
|
|||||
|
2020
Q2 | $1.17M | Sell |
|
|||||
|
2020
Q1 | $1.17M | Buy |
|
|||||
|
2019
Q4 | $1.17M | Buy |
|
|||||
|
2019
Q3 | $959K | Sell |
|
|||||
|
2019
Q2 | $1.32M | Sell |
|
|||||
|
2019
Q1 | $1.3M | Sell |
|
|||||
|
2018
Q4 | $1.46M | Buy |
|
|||||
|
2018
Q3 | $1.2M | Buy |
|
|||||
|
2018
Q2 | $786K | Buy |
|
|||||
|
2018
Q1 | $765K | Sell |
|
|||||
|
2017
Q4 | $898K | Sell |
|
|||||
|
2017
Q3 | $887K | Sell |
|
|||||
|
2017
Q2 | $883K | Sell |
|
|||||
|
2017
Q1 | $1.04M | Buy |
|
|||||
|
2016
Q4 | $845K | Sell |
|
|||||
|
2016
Q3 | $886K | Sell |
|
|||||
|
2016
Q2 | $927K | Buy |
|
|||||
|
2016
Q1 | $758K | Sell |
|
|||||
|
2015
Q4 | $849K | Sell |
|
|||||
|
2015
Q3 | $896K | Sell |
|
|||||
|
2015
Q2 | $977K | Sell |
|
|||||
|
2015
Q1 | $1.55M | Buy |
|
|||||
|
2014
Q4 | $1.37M | Sell |
|
|||||
|
2014
Q3 | $1.41M | Sell |
|
|||||
|
2014
Q2 | $1.45M | Buy |
|
|||||
|
2014
Q1 | $1.57M | Sell |
|
|||||
|
2013
Q4 | $1.65M | Sell |
|
|||||
|
2013
Q3 | $2.07M | Buy |
|
|||||
|
2013
Q2 | $2.01M | Buy |
|